Video

Most Common Myth About Clinical Trials

Catriona Jamieson, M.D., Ph.D., Professor of Medicine, University of California, San Diego Health Moores Cancer Center, addresses a common myth about clinical trials.

Catriona Jamieson, M.D., Ph.D., Professor of Medicine, University of California, San Diego Health Moores Cancer Center, addresses a common myth about clinical trials.

People often think clinical trials benefit doctors and science more than they help the people who participate in them. Clinical trials are actually better, more advanced care.

To be able to get through the Food and Drug Administration's regulations today, the burden of proof to be able to do a clinical trial is much higher than in the past. The likelihood of responding well in a safety, tolerability and proof-of-concept study is much better, as well as trial studies in later phases.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of bald man.
Image of man.
Image of Kumar.
Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.
Melanoma is a key cancer type for developing and testing immunotherapies prior to broader clinical application across other malignancies.
Image of Dr. Kumar.
Photo of a woman with shoulder-length black hair wearing a blazer
Image of a woman wearing a headband and glasses
Image of man.